RAC - Charts & Price Action, page-16161

1. I’m ok tagging heyline as a disgruntled believer (they have some legit beef).
2. Dr t’s leaving is intriguing and unanswered. I care, or at least would like to know.
3. In a weak moment, I might take $10.
4. I do think DCB looks to be doing a good job.
5. I do struggle with patience, (not alone of course), because I think we have something special, and there have been several delays or re-forecasts

one great point that you make, is that all the discussion here is on the finer details of the CoH collaboration, but it does seem like it’s pretty much a done deal… an agreement with COH would be amazing (we might even see some patients enrolled in clinical trials). Something is brewing.